Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1966 1
1967 1
1975 1
1983 2
1984 4
1994 2
1998 1
2000 2
2001 1
2002 1
2003 1
2004 3
2005 4
2006 7
2007 6
2008 5
2009 3
2010 6
2011 6
2012 5
2013 5
2014 4
2015 7
2016 7
2017 6
2018 5
2019 8
2020 18
2021 17
2022 16
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients.
Shiota M, Terada N, Saito T, Yokomizo A, Kohei N, Goto T, Kawamura S, Hashimoto Y, Takahashi A, Kimura T, Tabata KI, Tomida R, Hashimoto K, Sakurai T, Shimazui T, Sakamoto S, Kamiyama M, Tanaka N, Mitsuzuka K, Kato T, Narita S, Yasumoto H, Teraoka S, Kato M, Osawa T, Nagumo Y, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Inoue T, Mizowaki T, Kamoto T, Kojima T, Kitamura H, Sugimoto M, Nishiyama H, Eto M; Japanese Urological Oncology Group (JUOG). Shiota M, et al. Among authors: nagumo y. Cancer Sci. 2021 Apr;112(4):1524-1533. doi: 10.1111/cas.14722. Epub 2021 Feb 13. Cancer Sci. 2021. PMID: 33159829 Free PMC article.
Bmal1 Regulates Prostate Growth via Cell-Cycle Modulation.
Ueda M, Kono J, Sengiku A, Nagumo Y, Mathis BJ, Shimba S, Taketo MM, Kobayashi T, Ogawa O, Negoro H. Ueda M, et al. Among authors: nagumo y. Int J Mol Sci. 2022 Sep 24;23(19):11272. doi: 10.3390/ijms231911272. Int J Mol Sci. 2022. PMID: 36232573 Free PMC article.
Unexpected Rearrangement Reactions of the 14-Aminonaltrexone Skeleton.
Maeda K, Ohrui S, Tokuda A, Nagumo Y, Yamamoto N, Tanimura R, Saitoh T, Kutsumura N, Nagase H. Maeda K, et al. Among authors: nagumo y. Org Lett. 2023 May 19;25(19):3407-3411. doi: 10.1021/acs.orglett.3c00956. Epub 2023 May 8. Org Lett. 2023. PMID: 37154730
[Rare Cancers in the Genitourinary Tract].
Nagumo Y, Kandori S, Nishiyama H. Nagumo Y, et al. Gan To Kagaku Ryoho. 2020 Jul;47(7):1026-1030. Gan To Kagaku Ryoho. 2020. PMID: 32668844 Japanese.
Pertuzumab for the treatment of ovarian cancer.
Langdon SP, Faratian D, Nagumo Y, Mullen P, Harrison DJ. Langdon SP, et al. Among authors: nagumo y. Expert Opin Biol Ther. 2010 Jul;10(7):1113-20. doi: 10.1517/14712598.2010.487062. Expert Opin Biol Ther. 2010. PMID: 20465533 Review.
Design and Synthesis of Orexin 1 Receptor-Selective Agonists.
Iio K, Hashimoto K, Nagumo Y, Amezawa M, Hasegawa T, Yamamoto N, Kutsumura N, Takeuchi K, Ishikawa Y, Yamamoto H, Tokuda A, Sato T, Uchida Y, Inoue A, Tanimura R, Yanagisawa M, Nagase H, Saitoh T. Iio K, et al. Among authors: nagumo y. J Med Chem. 2023 Apr 27;66(8):5453-5464. doi: 10.1021/acs.jmedchem.2c01773. Epub 2023 Apr 12. J Med Chem. 2023. PMID: 37043436
153 results